Peptide-drug Conjugate Information
General Information of This Peptide-drug Conjugate (PDC)
| PDC ID |
PDC_00001
|
|||||
|---|---|---|---|---|---|---|
| PDC Name |
([α,β-3H]Nal)Lu-PSMA-617
|
|||||
| PDC Status |
Investigative
|
|||||
| Indication |
In total 1 Indication(s)
Metastatic castration-resistant prostate cancer
|
|||||
| Structure |
|
|||||
| Peptide Name |
PSMA-617
|
Peptide Info | ||||
| Receptor Name |
Glutamate carboxypeptidase 2 (FOLH1)
|
Receptor Info | ||||
| Drug Name |
Lutetium-175
|
Drug Info | ||||
| Therapeutic Target |
Human Deoxyribonucleic acid (hDNA)
|
Target Info | ||||
| Linker Name |
(S)-2-(4-(aminomethyl)cyclohexane-1-carboxamido)-3-(naphthalen-2-yl)propanoic acid
|
Linker Info | ||||
| Peptide Modified Type |
The modification of binding with chemical molecules
|
|||||
| Modified Segment |
Urea
|
|||||
| Formula |
C49H68LuN9O16
|
|||||
| #Ro5 Violations (Lipinski): 5 | Molecular Weight | 1218.113099 | ||||
| Lipid-water partition coefficient (xlogp) | -4.3821 | |||||
| Hydrogen Bond Donor Count (hbonddonor) | 8 | |||||
| Hydrogen Bond Acceptor Count (hbondacc) | 17 | |||||
| Rotatable Bond Count (rotbonds) | 27 | |||||